Characterization of the cellular and humoral immune response to outer surface protein C and outer surface protein 17 in children with early disseminated Lyme borreliosis

Medical Microbiology and Immunology

Volumn 189, Issue 4, 2001, Pages 193-200

  Pohl Koppe, Annette ^a   Kaunicnik, Angelika ^a   Wilske, Bettina ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Borrelia burgdorferi; Cellular immunity; Humoral immunity; OspC; Ospl7

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME AXETIL; DOXYCYCLINE; ERYTHROMYCIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN 17; OUTER MEMBRANE PROTEIN C; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBIOTIC THERAPY; ANTIBODY RESPONSE; ARTICLE; BORRELIA BURGDORFERI; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOREACTIVITY; LYME DISEASE; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TREATMENT OUTCOME;

EID: 0034854066     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004300100062     Document Type: Article

References (43)

1. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis
2. Serum-mediated resolution of Lyme arthritis in mice
3. Erythema chronicum migrans: Evidence for cellular immune reaction in the skin lesion
4. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatits chronica atrophicans, lymphadenosis benigna cutis and morphea
5. Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis
6. Lyme-Borreliose
7. Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicenter study with special regard to neuroborreliosis
8. Specific immune responses in Lyme borreliosis: Characterization of T cell and B cell responses to Borrelia burgdorferi
9. Seronegative Lyme disease
10. The T cell proliferative assay in the diagnosis of Lyme disease
11. Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus ticks removed from humans
12. Humoral immune responses to outer surface protein C of Borrelia burgdorferiin Lymedisease: Role of the immunoglobulin M response in the serodiagnosis of early infection
13. The cellular immune response to Bordetella pertussis in two children with whooping cough
14. Immunochemical characterization and isolation of the gene for a Borrelia burgdorferi immunodominant 60 kDa antigen common to a wide range of bacteria
15. Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato
16. Sustained cellular immune responses to Borrelia burgdorferi: Lack of correlation with clinical presentation and serology
17. Lymphoproliferative responses to Borrelia burgdorferi in the diagnosis of Lyme arthritis in children and adolescents
18. Ospl7, a novel immunodominant outer surface protein of Borrelia afzelii: Recombinant expression in Escherichia coli and its use as a diagnostic antigen for serodiagnosis of Lyme borreliosis
19. Dominant recognition of a Borrelia burgdorferi outer surface protein A peptide by T helper cells in patients with treatment-resistant Lyme arthritis
20. T cell proliferation induced by Borrelia burgdorferi in patients with Lyme borreliosis. Autologous serum required for optimum stimulation
21. Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis
22. The T helper cell response in Lyme arthritis: Differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis
23. Analysis of the human antibody response to outer surface protein C of Borrelia burgdorferi sensu stricto, B. garinii and B. afzelii
24. Borrelia lymphocytoma in childhood
25. Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection
26. Cross-reactivity of Borrelia burgdorferi and myelin basic protein-specific T cells is not observed in borrelial encephalomyelitis
27. Active immunization with pC protein of Borrelia burgdorferi protects gerbils against Borrelia burgdorferi infection
28. Prominent T lymphocyte response to Borrelia burgdorferi from peripheral blood of unexposed donors
29. Lyme borreliosis in the severe combined immunodeficiency (SCID) mouse manifests predominantly in the joints, heart, and liver
30. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding
31. Lyme disease: Pathogenesis and vaccine development
32. Microbiological diagnosis of Lyme borreliosis
33. Diagnostik der Lyme-neuroborreliose
34. An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis
35. Immunological and molecular polymorphism of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi
36. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay
37. Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato
38. Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development
39. Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany
40. An improved recombinant IgG immunoblot for serodiagnosis of Lyme borreliosis
41. T cell responses to polypeptide fractions of Borrelia burgdorferi in patients with Lyme arthritis
42. Therapeutic passive vaccination against chronic Lyme disease in mice
43. Lymphoproliferative responses to Borrelia burgdorferi in Lyme disease